IRMD Relative Valuation
IRMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IRMD is overvalued; if below, it's undervalued.
Historical Valuation
IRadimed Corp (IRMD) is now in the Fair zone, suggesting that its current forward PE ratio of 52.18 is considered Fairly compared with the five-year average of 37.71. The fair price of IRadimed Corp (IRMD) is between 78.03 to 105.63 according to relative valuation methord.
Relative Value
Fair Zone
78.03-105.63
Current Price：93.92
Fair
52.18
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
IRadimed Corp. (IRMD) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
40.65
EV/EBIT
IRadimed Corp. (IRMD) has a current EV/EBIT of 40.65. The 5-year average EV/EBIT is 27.06. The thresholds are as follows: Strongly Undervalued below 15.15, Undervalued between 15.15 and 21.11, Fairly Valued between 33.02 and 21.11, Overvalued between 33.02 and 38.97, and Strongly Overvalued above 38.97. The current Forward EV/EBIT of 40.65 falls within the Strongly Overvalued range.
13.48
PS
IRadimed Corp. (IRMD) has a current PS of 13.48. The 5-year average PS is 8.51. The thresholds are as follows: Strongly Undervalued below 5.33, Undervalued between 5.33 and 6.92, Fairly Valued between 10.11 and 6.92, Overvalued between 10.11 and 11.70, and Strongly Overvalued above 11.70. The current Forward PS of 13.48 falls within the Strongly Overvalued range.
0.00
P/OCF
IRadimed Corp. (IRMD) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
IRadimed Corp. (IRMD) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
IRadimed Corp (IRMD) has a current Price-to-Book (P/B) ratio of 12.15. Compared to its 3-year average P/B ratio of 7.93 , the current P/B ratio is approximately 53.23% higher. Relative to its 5-year average P/B ratio of 7.30, the current P/B ratio is about 66.41% higher. IRadimed Corp (IRMD) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.84%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 1.92% , the current FCF yield is about -100.00% lower.
12.15
P/B
Median3y
7.93
Median5y
7.30
1.24
FCF Yield
Median3y
1.84
Median5y
1.92
Competitors Valuation Multiple
The average P/S ratio for IRMD's competitors is 0.00, providing a benchmark for relative valuation. IRadimed Corp Corp (IRMD) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 15.69%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IRMD increased by 70.76% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 35.67 to 56.93.
The secondary factor is the Revenue Growth, contributed 15.69%to the performance.
Overall, the performance of IRMD in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is IRadimed Corp (IRMD) currently overvalued or undervalued?
What is IRadimed Corp (IRMD) fair value?
How does IRMD's valuation metrics compare to the industry average?
What is the current P/B ratio for IRadimed Corp (IRMD) as of Dec 05 2025?
What is the current FCF Yield for IRadimed Corp (IRMD) as of Dec 05 2025?
What is the current Forward P/E ratio for IRadimed Corp (IRMD) as of Dec 05 2025?